Cargando…
LIF and the lung’s stem cell niche: is failure to use LIF to protect against COVID-19 a grave omission in managing the pandemic?
What tips the SARS/COVID-19 balance into severe pneumonia, rather than recovery? Is it insufficient LIF – the lung’s own protective growth factor at the blood–air barrier?
Autor principal: | Metcalfe, Su M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643387/ http://dx.doi.org/10.2217/fvl-2020-0340 |
Ejemplares similares
-
Multiple Sclerosis and the LIF/IL-6 Axis: Use of Nanotechnology to Harness the Tolerogenic and Reparative Properties of LIF
por: Metcalfe, Su M., et al.
Publicado: (2015) -
COVID-19 lockdown: de-risking exit by protecting the lung with leukaemia inhibitory factor (LIF)
por: Metcalfe, Su M.
Publicado: (2020) -
LIF signal in mouse embryonic stem cells
por: Ohtsuka, Satoshi, et al.
Publicado: (2015) -
LIF is essential for ISC function and protects against radiation-induced gastrointestinal syndrome
por: Wang, Huaying, et al.
Publicado: (2020) -
Novel focused OCT-LIF endoscope
por: Wall, R. Andrew, et al.
Publicado: (2011)